| Polygenic risk scores for prediction of breast cancer and breast cancer subtypes N Mavaddat, K Michailidou, J Dennis, M Lush, L Fachal, A Lee, JP Tyrer, ... The American Journal of Human Genetics 104 (1), 21-34, 2019 | 903 | 2019 |
| Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families X Yang, G Leslie, A Doroszuk, S Schneider, J Allen, B Decker, ... Journal of clinical oncology 38 (7), 674-685, 2020 | 351 | 2020 |
| Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D X Yang, H Song, G Leslie, C Engel, E Hahnen, B Auber, J Horváth, K Kast, ... JNCI: Journal of the National Cancer Institute 112 (12), 1242-1250, 2020 | 140 | 2020 |
| Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants S Li, V Silvestri, G Leslie, TR Rebbeck, SL Neuhausen, JL Hopper, ... Journal of Clinical Oncology 40 (14), 1529-1541, 2022 | 137 | 2022 |
| Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants DR Barnes, MA Rookus, L McGuffog, G Leslie, TM Mooij, J Dennis, ... Genetics in Medicine 22 (10), 1653-1666, 2020 | 101 | 2020 |
| Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells CJM Bell, Y Sun, UM Nowak, J Clark, S Howlett, ML Pekalski, X Yang, ... Journal of Autoimmunity 56, 66-80, 2015 | 95 | 2015 |
| Cells with Treg-specific FOXP3 demethylation but low CD25 are prevalent in autoimmunity RC Ferreira, HZ Simons, WS Thompson, DB Rainbow, X Yang, AJ Cutler, ... Journal of Autoimmunity 84, 75-86, 2017 | 80 | 2017 |
| Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factors A Lee, X Yang, J Tyrer, A Gentry-Maharaj, A Ryan, N Mavaddat, ... Journal of medical genetics 59 (7), 632-643, 2022 | 46 | 2022 |
| Evaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort study X Yang, G Leslie, A Gentry-Maharaj, A Ryan, M Intermaggio, A Lee, ... Journal of medical genetics 55 (8), 546-554, 2018 | 45 | 2018 |
| Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study X Yang, M Eriksson, K Czene, A Lee, G Leslie, M Lush, J Wang, J Dennis, ... Journal of medical genetics 59 (12), 1196-1205, 2022 | 36 | 2022 |
| Polygenic risk modeling for prediction of epithelial ovarian cancer risk EO Dareng, JP Tyrer, DR Barnes, MR Jones, X Yang, KKH Aben, ... European Journal of Human Genetics 30 (3), 349-362, 2022 | 33 | 2022 |
| External validation of risk prediction models incorporating common genetic variants for incident colorectal cancer using UK Biobank CL Saunders, B Kilian, DJ Thompson, LJ McGeoch, SJ Griffin, ... Cancer Prevention Research 13 (6), 509-520, 2020 | 29 | 2020 |
| Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores DR Barnes, V Silvestri, G Leslie, L McGuffog, J Dennis, X Yang, J Adlard, ... JNCI: Journal of the National Cancer Institute 114 (1), 109-122, 2022 | 26 | 2022 |
| Epigenetic analysis of regulatory T cells using multiplex bisulfite sequencing DB Rainbow, X Yang, O Burren, ML Pekalski, DJ Smyth, MDR Klarqvist, ... European Journal of Immunology 45 (11), 3200, 2015 | 25 | 2015 |
| Population study of ovarian cancer risk prediction for targeted screening and prevention F Gaba, O Blyuss, X Liu, S Goyal, N Lahoti, D Chandrasekaran, M Kurzer, ... Cancers 12 (5), 1241, 2020 | 23 | 2020 |
| Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants H Li, C Engel, M De la Hoya, P Peterlongo, D Yannoukakos, L Livraghi, ... Genetics in Medicine 24 (1), 119-129, 2022 | 15 | 2022 |
| CanRisk-prostate: a comprehensive, externally validated risk model for the prediction of future prostate cancer T Nyberg, MN Brook, L Ficorella, A Lee, J Dennis, X Yang, N Wilcox, ... Journal of Clinical Oncology 41 (5), 1092, 2023 | 12 | 2023 |
| Polygenic scores in cancer X Yang, S Kar, AC Antoniou, PDP Pharoah Nature reviews Cancer 23 (9), 619-630, 2023 | 8 | 2023 |
| Extra-binomial variation approach for analysis of pooled DNA sequencing data X Yang, JA Todd, D Clayton, C Wallace Bioinformatics 28 (22), 2898-2904, 2012 | 7 | 2012 |
| J Med Genet X Yang, M Eriksson, K Czene | 5 | 2022 |
Douglas EastonProfessor of Genetic Epidemiology, University of CambridgeVerified email at medschl.cam.ac.uk
